The Dexcom G5® Mobile Continuous Glucose Monitoring (CGM) System is the first FDA-approved CGM that lets you make treatment decisions without pricking your finger.* It provides real-time glucose readings for patients with type 1 or type 2 diabetes every five minutes. With the Dexcom G5 Mobile, dynamic glucose data can be accessed and shared safely with up to 5 followers† anywhere, anytime to your smart device.‡ The Dexcom G5 Mobile is a CGM system approved for adults and pediatric patients two years of age and older.§
*CGM-based treatment requires fingersticks for calibration, if patient is taking acetaminophen, or if symptoms/expectations do not match CGM readings, and if not performed, may result in hypoglycemia. Important risk info.
†Separate Follow app required
‡For a list of compatible devices, visit www.dexcom.com/compatibility
§Dexcom G5 Mobile user guide, 2017.